🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Liangren Liu

Sichuan University

ORCID: 0000-0001-7597-6241

Also affiliated with West China Hospital of Sichuan University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models”.

Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models

Pharmacological Research(2023)10.1016/j.phrs.2023.106692
N/A
0.681DataRank · unranked
22 citations

Joy C. Yang, Shu Ning, Bo Chen, Christopher Nip, Qiang Wei +7 more

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer

Nature Communications(2024)10.1038/s41467-024-50459-x
N/A
0DataRank · unranked
10 citations

Joy C. Yang, Bo Chen, Shu Ning, Xiong Zhang, Leyi Wang +16 more

Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer

Oncogene(2024)10.1038/s41388-024-03081-6
N/A
0DataRank · unranked
5 citations

Pengfei Xu, Joy C. Yang, Christopher Nip, Leyi Wang, Yuqiu Shen +9 more

Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer

Research Square(2024)10.21203/rs.3.rs-4095949/v1
N/A
0DataRank · unranked
0 citations

Bo Chen, Pengfei Xu, Joy C. Yang, Christopher Nip, Leyi Wang +9 more